Author

Wietske Kievit 1

1 Radboudumc,Nijmegen,Netherlands

A RANDOMIZED TRIAL OF FLUID HYDRATION TO PREVENT POST-ERCP PANCREATITIS (FLUYT)

Christa J. Sperna Weiland, Xavier J. N. M. Smeets, Wietske Kievit, Robert C. Verdonk, Alexander C. Poen, Abha Bhalla, Niels G. Venneman, Ben J.M. Witteman, David W. da Costa, Brechje C. van Eijck, Matthijs P. Schwartz, Tessa E.H. Römkens, Jan Maarten Vrolijk, Muhammed Hadithi, Annet M. C. J. Voorburg, Lubbertus C. Baak, Wil

AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLYCYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRY

René van Aerts, Michiel de Jong, Wietske Kievit, Frederik Nevens, Hyunsuk Kim, Curie Ahn, Joost P.H. Drenth

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Reinier C. A. van Linschoten, Fenna Minke Jansen, Renske W. M. Pauwels, Lisa J. T. Smits, Femke Atsma, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E. H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Ma

Complications of Percutaneous Transhepatic Cholangiography and Biliary Drainage (PTCD)

Ayla Turan, Sjoerd Jenniskens, Leo J Schultze Kool, Jasper M. Martens, Matthieu J.C.M. Rutten, Lonneke S.F. Yo, Marco J.L. van Strijen, Wietske Kievit, Joost P.H. Drenth, Peter D. Siersema, Erwin J.M. Van Geenen

COMPROMISED SAFETY OF FIRST GENERATION PROTEASE INHIBITORS IN CHRONIC HEPATITIS C PATIENTS WHO DO NOT MEET INCLUSION CRITERIA FOR REGISTRATION TRIALS. NATIONWIDE REAL-WORLD EXPERIENCE

Floor Berden, Robert J de Knegt, Jan den Hollander, Marit G.A. van Vonderen, Pieter Friederich, Bart van Hoek, Karin M.J. van Nieuwkerk, Joost P.H. Drenth, Wietske Kievit

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Fenna Minke Jansen, Reinier C. A. van Linschoten, Renske Wilhelmina Maria Pauwels, Lisa S. Smits, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E.H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Maurice G

DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C GENOTYPE 3: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Floor Berden, Bryan RRZ Aaldering, Hans Groenewoud, Joanna IntHout, Wietske Kievit, Joost P.H. Drenth

DRUG HOLIDAY IN PATIENTS WITH POLYCYSTIC LIVER DISEASE TREATED WITH SOMATOSTATIN ANALOGUES: A NOVEL TREATMENT STRATEGY

René M.M. van Aerts, Marieke Kolkman, Wietske Kievit, Tom Johannes Gerardus Gevers, Frederik Nevens, Joost P.H. Drenth

HIGH RISK OF INFECTION DURING TRIPLE THERAPY WITH FIRST-GENERATION PROTEASE INHIBITORS: A NATIONWIDE RETROSPECTIVE COHORT STUDY

Floor Berden, Inke van Zwietering, Raoel Maan, Robert J de Knegt, Wietske Kievit, Joost P.H. Drenth

INCIDENCE OF MALIGNANT PROGRESSION IN PERSISTENT NONDYSPLASTIC BARRETT'S ESOPHAGUS - A DUTCH NATIONWIDE COHORT STUDY

Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens, Wiebe Pestman, Iris D. Nagtegaal, Peter D. Siersema

Item 1 - 10 / 19
1
2